Haimiao Biotech brought its innovative IVD series products to the MEDICA 2022 Medical Equipment Exhibition in Germany, attracting many professionals, including medical device agents, researchers, and various participants. The products on display won unanimous praise. On November 15, at the invitation of Düsseldorf Economic Promotion Bureau, Dr. Tammy Tan, Chairman of HymonBio and Mr. Sun Wentao, Deputy General Manager, attended the exchange dinner on behalf of Chinese enterprises.
The banquet was located at Rolandstraße 44, Düsseldorf, where guests can discuss about future plans and make connections while enjoying the beautiful scenery and Rheinturm. Local institutions and companies and international companies were invited to participate in the event.
Dr. Tammy Tan and Mr. Sun Wentao had in-depth conversations with participating corporate guests and discussed future developments and application of international clinical diagnosis and treatment using molecular reagent technologies, and how to better benefit patients globally. Dr. Tan said HymonBio has always taken technological innovation as a starting point, leading to many breakthroughs.
HymonBio has developed the “one-step” method, effectively solving the complications associated with nucleic acid extraction by cutting down completion time to 3 minutes. This technology has been applied to many products, including the Hymon® SARS-CoV-2 Test Kit, which has been recognized by the FDA-EUA and cited by its former director.
The participating experts acknowledged HymonBio’s technologies and expressed their willingness to extend international cooperation with the company, and jointly strive to better serve patients in need around the world.
Post time: Nov-16-2022